Curcumin effect on athresclerosis plaqua in coronary artery disease
Phase 2
Completed
- Conditions
- Coronary artery disease.Atherosclerotic heart disease
- Registration Number
- IRCT201112028276N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
age more than 18 and diagnosis of coronary artery disease according to angiography results
Exclusion criteria: severe renal or hepatic failure; having infectious disease; use of immunosuppressive or anti inalmmatory drugs; curcumin sensitivity; pregnancy and lactation.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IL-18. Timepoint: Before and 2 month after begining of study. Method of measurement: Kit.;CD40L. Timepoint: Before and 2 month after begining of study. Method of measurement: Kit.;MMP-9. Timepoint: Before and 2 month after begining of study. Method of measurement: Kit.;MPO. Timepoint: Before and 2 month after begining of study. Method of measurement: Kit.;VCAM-1. Timepoint: Before and 2 month after begining of study. Method of measurement: Kit.;MCP-1. Timepoint: Before and 2 month after begining of study. Method of measurement: Kit.
- Secondary Outcome Measures
Name Time Method